Skip to content
Subscriber Only

Merck Australia Wins Bid to Overturn Vioxx Trial Decision

Merck & Co.’s Australian unit won a bid to overturn the first trial decision outside the U.S. that said the drugmaker failed to warn of heart risks associated with its painkiller Vioxx.

The judgment against Merck should be set aside and the action should be dismissed, Justice Michelle Gordon said on behalf of the appeal panel in Federal Court in Melbourne today. The decision reverses a March 5, 2010, ruling that awarded Graeme Robert Peterson A$287,912 ($286,000), after he found Vioxx contributed to Peterson’s heart attack in 2003.